Anthera is currently conducting two studies with Sollpura.
Solution Study: The purpose of the SOLUTION study is to evaluate the non-inferiority of Sollpura compared to approved, porcine-derived, enterically-coated pancreatic enzyme replacement therapy when administered to patients with cystic fibrosis and endocrine pancreatic insufficiency. Learn more.
Simplicity Study: The SIMPLICITY study will evaluate the safety and efficacy of Sollpura powder for oral solution, supplied in sachets. Learn more.